1. COUNSELLING AND GENETIC TESTING FOR BREAST AND OVARIAN CANCER SUSCEPTIBILITY – THE GERMAN MODEL. Issue 1 (1st March 2003) Authors: Ditsch, N. C.; Nestle-Kraemling, C.; Bauerfeind, I.; Schmidt, D.; Straub, J.; Vodermaier, A.; Meindl, A.; Untch, M. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 1(2003) Supplement Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Endocrine sensitivity is decisive for patient outcome in small node-negative breast cancers (BC) (pT1a, b) – Results from the Munich Cancer Registry. Issue 1 (February 2015) Authors: Kolben, T.; Harbeck, N.; Wuerstlein, R.; Schubert-Fritschle, G.; Bauerfeind, I.; Schrodi, S.; Engel, J. Journal: Breast Issue: Volume 24:Issue 1(2015) Page Start: 24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. German Adjuvant Intergroup Node-positive Study (GAIN): a phase III trial comparing two dose-dense regimens (iddEPC versus ddEC-PwX) in high-risk early breast cancer patients. (28th April 2017) Authors: Möbus, V.; von Minckwitz, G.; Jackisch, C.; Lück, H.-J.; Schneeweiss, A.; Tesch, H.; Elling, D.; Harbeck, N.; Conrad, B.; Fehm, T.; Huober, J.; Müller, V.; Bauerfeind, I.; du Bois, A.; Loibl, S.; Nekljudova, V.; Untch, M.; Thomssen, C. Journal: Annals of oncology Issue: Volume 28:Number 8(2017) Page Start: 1803 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P087 Endocrine sensitivity is decisive for patient outcome in small PN0 breast cancers (PT1A, b). (March 2015) Authors: Kolben, T.; Wuerstlein, R.; Harbeck, N.; Schubert-Fritschle, G.; Bauerfeind, I.; Schrodi, S.; Engel, J. Journal: Breast Issue: Volume 24(2015)Supplement 1 Page Start: S55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SURGICAL OUTCOME AFTER PRIMARY SYSTEMIC CHEMOTHERAPY - RESULTS OF THE RANDOMISED DOSE DENSE AGO-STUDY (MUNICH PROTOCOL). Issue 1 (1st March 2003) Authors: Bauerfeind, I.; Nestle-Kramling, C.; Kahlert, S.; Ditsch, N.; Hasmuller, S.; Untch, M. Journal: International journal of gynecological cancer Issue: Volume 13:Issue 1(2003) Supplement Page Start: 3 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The West German Study Group Breast Cancer Intrinsic Subtype study: a prospective multicenter decision impact study utilizing the Prosigna assay for adjuvant treatment decision-making in estrogen-receptor-positive, HER2-negative early-stage breast cancer. (2nd July 2016) Authors: Wuerstlein, R.; Sotlar, K.; Gluz, O.; Otremba, B.; von Schumann, R.; Witzel, I.; Schindlbeck, C.; Janni, W.; Schem, C.; Bauerfeind, I.; Hasmueller, S.; Tesch, H.; Paulenz, A.; Ghali, N.; Orujov, E.; Kates, R. E.; Cowens, W.; Hornberger, J.; Pelz, E.; Harbeck, N. Journal: Current medical research and opinion Issue: Volume 32:Number 7(2016:Jul.) Page Start: 1217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗